Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents

Journal of Hospital Infection

Volumn 104, Issue 3, 2020, Pages 246-251

  Kampf, G ^a   Todt, D ^b   Pfaender, S ^b   Steinmann, E ^b  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Biocidal agents; Chemical inactivation; Coronavirus; Disinfection; Inanimate surfaces; Persistence

Indexed keywords

ALCOHOL; BENZALKONIUM CHLORIDE; BIOCIDE; CHLORHEXIDINE GLUCONATE; GLASS; HYDROGEN PEROXIDE; HYPOCHLORITE SODIUM; METAL; PLASTIC; COVID-19; DISINFECTANT AGENT; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2;

CANINE CORONAVIRUS; CLINICAL EFFECTIVENESS; CORONAVIRINAE; CORONAVIRUS DISEASE 2019; CORONAVIRUS INFECTION; DISINFECTION; HEALTH CARE FACILITY; HEPATITIS VIRUS; HUMAN; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; REVIEW; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SURFACE AREA; TRANSMISSIBLE GASTROENTERITIS VIRUS; VIRUS INACTIVATION; VIRUS TRANSMISSION; BETACORONAVIRUS; DRUG EFFECT; ENVIRONMENTAL MICROBIOLOGY; GROWTH, DEVELOPMENT AND AGING; MICROBIAL VIABILITY; VIRUS PNEUMONIA;

BETACORONAVIRUS; CORONAVIRUS INFECTIONS; DISINFECTANTS; ENVIRONMENTAL MICROBIOLOGY; HUMANS; MICROBIAL VIABILITY; PNEUMONIA, VIRAL;

EID: 85079891308     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2020.01.022     Document Type: Review

References (41)

1. WHO, Coronavirus Disease 2019 (COVID-19)., 2020, WHO Situation Report 23.
2. de Wit, E., van Doremalen, N., Falzarano, D., Munster, V.J., SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol 14 (2016), 523–534.
3. Chan, J.F., Yuan, S., Kok, K.H., To, K.K., Chu, H., Yang, J., et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet, 2020, 10.1016/s0140-6736(20)30154-9.
4. Otter, J.A., Donskey, C., Yezli, S., Douthwaite, S., Goldenberg, S.D., Weber, D.J., Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. J Hosp Infect 92 (2016), 235–250.
5. Dowell, S.F., Simmerman, J.M., Erdman, D.D., Wu, J.S., Chaovavanich, A., Javadi, M., et al. Severe acute respiratory syndrome coronavirus on hospital surfaces. Clin Infect Dis 39 (2004), 652–657.
6. Geller, C., Varbanov, M., Duval, R.E., Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies. Viruses 4 (2012), 3044–3068.
7. Kampf, G., Antiseptic stewardship: biocide resistance and clinical implications. 2018, Springer International Publishing, Cham.
8. Ijaz, M.K., Brunner, A.H., Sattar, S.A., Nair, R.C., Johnson-Lussenburg, C.M., Survival characteristics of airborne human coronavirus 229E. J Gen Virol 66:Pt 12 (1985), 2743–2748.
9. Bean, B., Moore, B.M., Sterner, B., Peterson, L.R., Gerding, D.N., Balfour, H.H., Survival of influenza viruses an environmental surfaces. J Infect Dis 146 (1982), 47–51.
10. Ansari, S.A., Springthorpe, V.S., Sattar, S.A., Rivard, S., Rahman, M., Potential role of hands in the spread of respiratory viral infections: studies with human parainfluenza virus 3 and rhinovirus 14. J Clin Microbiol 29 (1991), 2115–2119.
11. Kwok, Y.L., Gralton, J., McLaws, M.L., Face touching: a frequent habit that has implications for hand hygiene. Am J Infect Contr 43 (2015), 112–114.
12. WHO, Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected. 2020, WHO Interim guidance. 25 January 2020.
13. WHO. Annex G, Use of disinfectants: alcohol and bleach. Infection prevention and control of epidemic-and pandemic-prone acute respiratory infections in health care. 2014, WHO, Geneva, 65–66.
14. Siddharta, A., Pfaender, S., Vielle, N.J., Dijkman, R., Friesland, M., Becker, B., et al. Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses. J Infect Dis 215 (2017), 902–906.
15. Yen, M.Y., Lu, Y.C., Huang, P.H., Chen, C.M., Chen, Y.C., Lin, Y.E., Quantitative evaluation of infection control models in the prevention of nosocomial transmission of SARS virus to healthcare workers: implication to nosocomial viral infection control for healthcare workers. Scand J Infect Dis 42 (2010), 510–515.
16. Alshammari, M., Reynolds, K.A., Verhougstraete, M., O'Rourke, M.K., Comparison of perceived and observed hand hygiene compliance in healthcare workers in MERS-CoV endemic regions. Healthcare (Basel, Switzerland), 6, 2018, 122.
17. Al-Tawfiq, J.A., Abdrabalnabi, R., Taher, A., Mathew, S., Rahman, K.A., Infection control influence of Middle East respiratory syndrome coronavirus: A hospital-based analysis. Am J Infect Contr 47 (2019), 431–434.
18. Wong, T.W., Tam, W.W., Handwashing practice and the use of personal protective equipment among medical students after the SARS epidemic in Hong Kong. Am J Infect Contr 33 (2005), 580–586.
19. Wiboonchutikul, S., Manosuthi, W., Likanonsakul, S., Sangsajja, C., Kongsanan, P., Nitiyanontakij, R., et al. Lack of transmission among healthcare workers in contact with a case of Middle East respiratory syndrome coronavirus infection in Thailand. Antimicrob Resist Infect Control, 5, 2016, 21.
20. Ki, H.K., Han, S.K., Son, J.S., Park, S.O., Risk of transmission via medical employees and importance of routine infection-prevention policy in a nosocomial outbreak of Middle East respiratory syndrome (MERS): a descriptive analysis from a tertiary care hospital in South Korea. BMC Pulm Med, 19, 2019, 190.
21. van Doremalen, N., Bushmaker, T., Munster, V.J., Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions. Euro Surveill, 18, 2013.
22. Casanova, L.M., Jeon, S., Rutala, W.A., Weber, D.J., Sobsey, M.D., Effects of air temperature and relative humidity on coronavirus survival on surfaces. Appl Environ Microbiol 76 (2010), 2712–2717.
23. Warnes, S.L., Little, Z.R., Keevil, C.W., Human Coronavirus 229E Remains Infectious on Common Touch Surface Materials. mBio 6 (2015), e01697–15.
24. Sizun, J., Yu, M.W., Talbot, P.J., Survival of human coronaviruses 229E and OC43 in suspension and after drying on surfaces: a possible source of hospital-acquired infections. J Hosp Infect 46 (2000), 55–60.
25. Duan, S.M., Zhao, X.S., Wen, R.F., Huang, J.J., Pi, G.H., Zhang, S.X., et al. Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation. Biomed Environ Sci 16 (2003), 246–255.
26. Lai, M.Y., Cheng, P.K., Lim, W.W., Survival of severe acute respiratory syndrome coronavirus. Clin Infect Dis 41 (2005), e67–e71.
27. Chan, K.H., Peiris, J.S., Lam, S.Y., Poon, L.L., Yuen, K.Y., Seto, W.H., The Effects of Temperature and Relative Humidity on the Viability of the SARS Coronavirus. Adv Virol, 2011, 734690.
28. Rabenau, H.F., Cinatl, J., Morgenstern, B., Bauer, G., Preiser, W., Doerr, H.W., Stability and inactivation of SARS coronavirus. Med Microbiol Immunol 194 (2005), 1–6.
29. Rabenau, H.F., Kampf, G., Cinatl, J., Doerr, H.W., Efficacy of various disinfectants against SARS coronavirus. J Hosp Infect 61 (2005), 107–111.
30. Saknimit, M., Inatsuki, I., Sugiyama, Y., Yagami, K., Virucidal efficacy of physico-chemical treatments against coronaviruses and parvoviruses of laboratory animals. Jikken Dobutsu Exp Anim 37 (1988), 341–345.
31. Wood, A., Payne, D., The action of three antiseptics/disinfectants against enveloped and non-enveloped viruses. J Hosp Infect 38 (1998), 283–295.
32. Pratelli, A., Action of disinfectants on canine coronavirus replication in vitro. Zoonoses Publ Health 54 (2007), 383–386.
33. Dellanno, C., Vega, Q., Boesenberg, D., The antiviral action of common household disinfectants and antiseptics against murine hepatitis virus, a potential surrogate for SARS coronavirus. Am J Infect Control 37 (2009), 649–652.
34. Omidbakhsh, N., Sattar, S.A., Broad-spectrum microbicidal activity, toxicologic assessment, and materials compatibility of a new generation of accelerated hydrogen peroxide-based environmental surface disinfectant. Am J Infect Control 34 (2006), 251–257.
35. Pratelli, A., Canine coronavirus inactivation with physical and chemical agents. Vet J (London, England : 1997) 177 (2008), 71–79.
36. Kariwa, H., Fujii, N., Takashima, I., Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents. Dermatol (Basel, Switzerland) 212:Suppl 1 (2006), 119–123.
37. Eggers, M., Eickmann, M., Zorn, J., Rapid and Effective Virucidal Activity of Povidone-Iodine Products Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and Modified Vaccinia Virus Ankara (MVA). Infect Dis Ther 4 (2015), 491–501.
38. Eggers, M., Koburger-Janssen, T., Eickmann, M., Zorn, J., In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle/Mouthwash Against Respiratory and Oral Tract Pathogens. Infect Dis Ther 7 (2018), 249–259.
39. Hulkower, R.L., Casanova, L.M., Rutala, W.A., Weber, D.J., Sobsey, M.D., Inactivation of surrogate coronaviruses on hard surfaces by health care germicides. Am J Infect Control 39 (2011), 401–407.
40. Sattar, S.A., Springthorpe, V.S., Karim, Y., Loro, P., Chemical disinfection of non-porous inanimate surfaces experimentally contaminated with four human pathogenic viruses. Epidemiol Infect 102 (1989), 493–505.
41. Goyal, S.M., Chander, Y., Yezli, S., Otter, J.A., Evaluating the virucidal efficacy of hydrogen peroxide vapour. J Hosp Infect 86 (2014), 255–259.